In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Origin Materials Inc (NASDAQ: ORGN) was $1.00 for the day, down -1.96% from the previous closing price of $1.02. In other words, the price has decreased by -$1.96 from its previous closing price. On the day, 1.28 million shares were traded. ORGN stock price reached its highest trading level at $1.02 during the session, while it also had its lowest trading level at $0.99.
Ratios:
Our analysis of ORGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.16 and its Current Ratio is at 16.27. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Lee Joshua C. sold 1,400 shares for $1.20 per share. The transaction valued at 1,673 led to the insider holds 628,385 shares of the business.
Lee Joshua C. bought 1,400 shares of ORGN for $1,631 on Jan 02 ’25. On Dec 27 ’24, another insider, Plavan Matthew T, who serves as the CFO and COO of the company, sold 24,500 shares for $1.02 each. As a result, the insider received 25,110 and left with 1,439,588 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 146250000 and an Enterprise Value of 39833688. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.16 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 1.169 whereas that against EBITDA is -0.702.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.88, which has changed by 0.64781904 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.90, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -11.75%, while the 200-Day Moving Average is calculated to be -12.18%.
Shares Statistics:
ORGN traded an average of 1.37M shares per day over the past three months and 1221590 shares per day over the past ten days. A total of 145.89M shares are outstanding, with a floating share count of 125.01M. Insiders hold about 14.52% of the company’s shares, while institutions hold 16.63% stake in the company. Shares short for ORGN as of 1730332800 were 3895543 with a Short Ratio of 4.20, compared to 1727654400 on 3417061. Therefore, it implies a Short% of Shares Outstanding of 3895543 and a Short% of Float of 3.09.
